These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9444987)

  • 1. DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector.
    Hariharan MJ; Driver DA; Townsend K; Brumm D; Polo JM; Belli BA; Catton DJ; Hsu D; Mittelstaedt D; McCormack JE; Karavodin L; Dubensky TW; Chang SM; Banks TA
    J Virol; 1998 Feb; 72(2):950-8. PubMed ID: 9444987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge.
    Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
    Antiviral Res; 1995 Oct; 28(2):147-57. PubMed ID: 8585768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.
    Kuklin N; Daheshia M; Karem K; Manickan E; Rouse BT
    J Virol; 1997 Apr; 71(4):3138-45. PubMed ID: 9060677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer.
    Dubensky TW; Driver DA; Polo JM; Belli BA; Latham EM; Ibanez CE; Chada S; Brumm D; Banks TA; Mento SJ; Jolly DJ; Chang SM
    J Virol; 1996 Jan; 70(1):508-19. PubMed ID: 8523564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections.
    Soleimanjahi H; Roostaee MH; Rasaee MJ; Mahboudi F; Kazemnejad A; Bamdad T; Zandi K
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):100-6. PubMed ID: 16420602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted.
    Farrell HE; McLean CS; Harley C; Efstathiou S; Inglis S; Minson AC
    J Virol; 1994 Feb; 68(2):927-32. PubMed ID: 8289395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination.
    Miller A; Center RJ; Stambas J; Deliyannis G; Doherty PC; Howard JL; Turner SJ; Purcell DF
    Vaccine; 2008 Oct; 26(44):5641-8. PubMed ID: 18761047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins.
    Nass PH; Elkins KL; Weir JP
    J Infect Dis; 1998 Sep; 178(3):611-7. PubMed ID: 9728527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
    Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of improved Sindbis virus-based DNA expression vector.
    Yamanaka R; Xanthopoulos KG
    DNA Cell Biol; 2004 Feb; 23(2):75-80. PubMed ID: 15000747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus vectors as potential vaccines against herpes simplex virus.
    Johnson DC
    Rev Infect Dis; 1991; 13 Suppl 11():S912-6. PubMed ID: 1664127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of humoral and cellular immune responses against hepatitis C virus by vaccination with replicon particles derived from Sindbis-like virus XJ-160.
    Zhu W; Fu J; Lu J; Deng Y; Wang H; Wei Y; Deng L; Tan W; Liang G
    Arch Virol; 2013 May; 158(5):1013-9. PubMed ID: 23250650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
    Yamanaka R; Xanthopoulos KG
    DNA Cell Biol; 2005 May; 24(5):317-24. PubMed ID: 15869409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection.
    Caselli E; Grandi P; Argnani R; Balboni PG; Selvatici R; Manservigi R
    Intervirology; 2001; 44(1):1-7. PubMed ID: 11223713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B.
    McDermott MR; Graham FL; Hanke T; Johnson DC
    Virology; 1989 Mar; 169(1):244-7. PubMed ID: 2538036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27.
    Manickan E; Yu Z; Rouse RJ; Wire WS; Rouse BT
    Viral Immunol; 1995; 8(2):53-61. PubMed ID: 8825290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D.
    Ghiasi H; Nesburn AB; Kaiwar R; Wechsler SL
    Arch Virol; 1991; 121(1-4):163-78. PubMed ID: 1662037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors.
    Polo JM; Belli BA; Driver DA; Frolov I; Sherrill S; Hariharan MJ; Townsend K; Perri S; Mento SJ; Jolly DJ; Chang SM; Schlesinger S; Dubensky TW
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4598-603. PubMed ID: 10200308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector.
    Manservigi R; Grossi MP; Gualandri R; Balboni PG; Marchini A; Rotola A; Rimessi P; Di Luca D; Cassai E; Barbanti-Brodano G
    J Virol; 1990 Jan; 64(1):431-6. PubMed ID: 2152829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.